期刊文献+

二甲双胍联合匹伐他汀治疗糖尿病合并高胆固醇血症疗效观察

下载PDF
导出
摘要 目的:探讨二甲双胍联合匹伐他汀治疗糖尿病合并高胆固醇血症的临床疗效。方法:选择2012年至2015年间我院收治的120例糖尿病合并高胆固醇血症患者为研究对象,随机将其分为对照组与观察组,每组各60例,观察组给予口服二甲双胍联合匹伐他汀、对照组给予口服二甲双胍联合阿托伐他汀。结果:与治疗前比较,观察组与对照组FPG、TC、TG、LDL-C、HDL-C均显著变化(P<0.05);观察组治疗后2h PBG、HbA1c明显降低(P<0.05),而对照组治疗前后无明显差异(P>0.05);治疗后观察组与对照组在FPG、2h PBG、HbA1c、HDL-C方面的差异有统计学意义(P<0.05)。结论:二甲双胍联合匹伐他汀治疗糖尿病合并高胆固醇血症疗效显著。
作者 王清玉
出处 《中外女性健康研究》 2015年第15期164-164,171,共2页 Women's Health Research
  • 相关文献

参考文献3

二级参考文献36

  • 1阳军,李向平,赵水平,李江,李敬东,谢晓明,彭俊.氟伐他汀早期干预对急性冠状动脉综合征患者血清炎症因子水平的影响[J].中华内科杂志,2005,44(3):184-187. 被引量:19
  • 2Betteridge J. Pitavastatin: Results from phase III and IV trials [J]. Atheroseler Suppl, 2010, 11 (3):8-14.
  • 3Morgan RE, Campbell SE, Yu CY, et al. Comparison of the Safety, Tolerability, and Pharmacokinetic Profile of a Single Oral Dose of Pitavastatin 4 mg in Adult Subjects With Severe Renal Impairment Not on Hemodialysis Versus Healthy Adult Subjects[J]. J Cardiovasc Pharmacol, 2012, 60(1 ) :42-48.
  • 4Kubo M, Egashira K, Inoue T, et al. Therapeutic neovascu larization by nanotechnology-mediated cell-selective delivery of pitavastatin into the vascular endothelium [J]. Arterioscler Thromb Vasc Biol, 2009, 29(6):796-801.
  • 5Yoshida O, Kondo T, Kureishi-Bando Y, et al. Pitavastatin, an HMG-CoA reductase inhibitor, ameliorates endothelial function in chronic smokers[J]. Circ J, 2010, 74(1): 195-202.
  • 6Suzuki H, Kobayashi H, Sato F, et al. Plaque-stabilizing effect of pitavastatin in Watanabe heritable hyperlipidemic (WHHL) rabbits[J]. J Atheroscler Thromb, 2003, 10 (2): 109-116.
  • 7Hiro T, Kimura T, Morimoto T, etal. Effect of intensive sta- tin therapy on regression of coronary atherosclerosis in patients with acute coronary syndrome: a multieenter randomized trial evaluated by volumetric intravascular ultrasound using pitavas- tatin versus atorvastatin (JAPAN-ACS [Japan assessment of pitavastatin and atorvastatin in acute coronary syndrome] stud- y) [J]. J Am Coil Cardiol, 2009, 54(4):293-302.
  • 8Nomura S, Taniura T, Shouzu A, etal. Effects of pitavastatin on plasminogen activator inhibitor-1 in hyperlipidemie patients [J]. Int J Gen Med, 2012, 5:535-540.
  • 9Nomura S, Shouzu A, Omoto S, et al. Effects of pitavastatin on monocyte chemoattractant protein-1 in hyperlipidemic pa- tients[J]. Blood Coagul Fibrinolysis, 2009, 20 (6) : 440-447.
  • 10Nomura S, Inami N, Shouzu A, et al. The effects of pitavas- tatin, eicosapentaenoic acid and combined therapy on platelet- derived microparticles and adiponectin in hyperlipidemic, dia- betic patients[J]. Platelets, 2009, 20(1) : 16-22.

共引文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部